David Shaw’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$503K Buy
+3,647
New +$541K ﹤0.01% 4246
2022
Q1
– Sell
-1,667
Closed -$504K – 6021
2021
Q4
$504K Buy
+1,667
New +$534K ﹤0.01% 4401
2021
Q3
– Sell
-968
Closed -$296K – 5287
2021
Q2
$296K Buy
968
+729
+305% +$160K ﹤0.01% 4286
2021
Q1
$49K Buy
+239
New +$52.2K ﹤0.01% 3967
2020
Q3
– Sell
-191
Closed -$47K – 4236
2020
Q2
$47K Sell
191
-40
-17% -$9.35K ﹤0.01% 3920
2020
Q1
$42K Sell
231
-148
-39% -$37.3K ﹤0.01% 3840
2019
Q4
$110K Sell
379
-718
-65% -$199K ﹤0.01% 3868
2019
Q3
$299K Buy
1,097
+15
+1% +$5.81K ﹤0.01% 3465
2019
Q2
$407K Buy
1,082
+165
+18% +$49.2K ﹤0.01% 3169
2019
Q1
$246K Buy
917
+293
+47% +$69.6K ﹤0.01% 3309
2018
Q4
$133K Buy
624
+323
+107% +$100K ﹤0.01% 3611
2018
Q3
$135K Buy
+301
New +$131K ﹤0.01% 3597

Other funds holding PVLA

David Shaw's PVLA Position: Q3 2026 in Review

David Shaw opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 3,647 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #4246 among its holdings. This is a return to the name: David Shaw previously reported a position in PVLA as recently as Q4 2021.

David Shaw first reported a position in PVLA in Q3 2018 and has held it in 12 quarters since. The position peaked at $504K in Q4 2021. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • David Shaw held 3,647 shares of Palvella Therapeutics worth $503K as of Q3 2026.
  • Palvella Therapeutics was a new David Shaw position in Q3 2026.
  • Palvella Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4246 holding.
  • David Shaw first reported a position in Palvella Therapeutics in Q3 2018 and has held it in 12 quarters since.
  • David Shaw's Palvella Therapeutics position peaked at $504K in Q4 2021.
  • 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.